In vitro and in vivo antidermatophyte activities of NND-502, a novel optically active imidazole antimycotic agent

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 4, 1998, Pages 967-970

  Niwano, Yoshimi ^a   Kuzuhara, Naoki ^a   Kodama, Hiroki ^a   Yoshida, Masanori ^a   Miyazaki, Tsuneo ^a   Yamaguchi, Hideyo ^b  

^a NIHON NOHYAKU CO LTD   (Japan)

^b TEIKYO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; LANOCONAZOLE; MACROGOL 400; TERBINAFINE; UNCLASSIFIED DRUG; [4 (2,4 DICHLOROPHENYL) 1,3 DITHIOLAN 2 YLIDENE] 1 IMIDAZOLYLACETONITRILE; [4 (2,4 DICHLOROPHENYL) 1,3 DITHIOLAN 2 YLIDENE](1 IMIDAZOLYL)ACETONITRILE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIFUNGAL ACTIVITY; DRUG EFFICACY; DRUG FORMULATION; DRUG POTENCY; GUINEA PIG; MALE; NONHUMAN; NOTE; PRIORITY JOURNAL; TINEA PEDIS; TOPICAL DRUG ADMINISTRATION; TRICHOPHYTOSIS;

EID: 0031966228     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.4.967     Document Type: Note

References (24)

1. Arika, T., M. Yokoo, and H. Yamaguchi. 1992. Butenafine, a new benzylamine derivative: in vitro effect on arthrospores of T. mentagrophytes and therapeutic efficacy on experimental tinea pedis in guinea pigs. Jpn. J. Med. Mycol. 33:541-547.
2. Arika, T., M. Yokoo, T. Maeda, K. Amemiya, and H. Yamaguchi. 1990. Effects of butenafine hydrochloride, a new benzylamine derivative, on experimental tinea pedis in guinea pigs. Antimicrob. Agents Chemother. 34: 2254-2255.
3. Cordero, C., I. de la Rosa, Z. Espinosa, R. F. Rojas, and N. Zaias. 1992. Short-term therapy of tinea cruris/corporis with topical terbinafine. J. Dermotol. Treatment 3(Suppl. 1):23-24.
4. Evans, E. G. V., B. Dodman, D. M. Williamson, G. J. Brown, and R. G. Bowen. 1993. Comparison of terbinafine and clotrimazole in treating tinea pedis. Br. Med. J. 307:645-647.
5. Evans, E. G. V., R. A. Seaman, and I. G. James. 1994. Short-duration therapy with terbinafine 1% cream in dermatophyte skin infections. Br. J. Dermatol. 130:83-87.
6. Fredriksson, T. 1983. Treatment of dermatomycoses with topical tioconazole and miconazole. Dermatologica 66(Suppl. 1):20-33.
7. Fujita, S., and T. Matsuyama. 1987. Experimental tinea pedis by non-abrasive inoculation of Trichophyton mentagrophytes arthrospores on the plantar part of guinea pig foot. J. Med. Vet. Mycol. 25:203-213.
8. Fujita, S., T. Matsuyama, and Y. Sato. 1988. Experimental tinea pedis in guinea pig feet-scanning electron microscopic and histological study of the infection. Jpn. J. Med. Mycol. 29:163-168.
9. Hirsch, H. A. 1989. Clinical evaluation of terconazole. European experience. J. Reprod. Med. 34:593-596.
10. Kodama, H., Y. Niwano, K. Kanai, and M. Yoshida. April 1997. Japanese patent (Jpn Koukai Tokkyo Kouhou) H9-100279.
11. Kokoschka, E. M., G. Niebauer, M. Mounari, and P. Monici Preti. 1986. Treatment of dermatomycoses with topical fenticonazole and econazole. Mykosen 29:45-50.
12. Kuokkanen, K. 1982. Topical tioconazole in dermatomycosis. Mykosen 25: 274-280.
13. McVie, D. H., S. Littlewood, B. R. Allen, A. C. Pollock, P. Wood, and L. J. Milne. 1986. Sulconazole versus clotrimazole in the treatment of dermatophytosis. Clin. Exp. Dermatol. 11:613-618.
14. Niwano, Y., T. Tabuchi, K. Kanai, H. Hamaguchi, K. Uchida, and H. Yamaguchi. 1995. Short-term topical therapy of experimental tinea pedis in guinea pigs with lanoconazole, a new imidazole antimycotic agent. Antimicrob. Agents Chemother. 39:2353-2355.
15. Ohmi, T., S. Konaka, M. Uchida, and H. Yamaguchi. 1991. Antifungal activity of a new agent latoconazole in two tinea models. Arzneim.-Forsch./Drug Res. 41:847-851.
16. Oka, H., Y. Niwano, T. Ohmi, T. Tanaka, M. Uchida, and H. Yamaguchi. 1992. Therapeutic efficacy of latoconazole in formulations of clinical use on experimental dermatophytosis in guinea pigs. Arzneim.-Forsch./Drug Res. 42:345-349.
17. Petranyi, G., N. S. Ryder, and A. Stütz. 1984. Allylamine derivatives: new class of synthetic antifungal agents inhibiting fungal squalene epoxidase. Science 224:1239-1241.
18. Seo, A., H. Kanno, N. Hasegawa, Y. Miyagi, and K. Ikeda. November 1985. Japanese patent (Jpn Koukai Tokkyo Kouhou) S60-218387.
19. Smith, E. B., J. L. Graham, and J. A. Ulrich. 1977. Topical clotrimazole in tinea pedis. South. Med. J. 70:47-48.
20. Stettendorf, S. 1983. Tolerability and efficacy of bifonazole in dermatomycoses. Arzneim.-Forsch./Drug Res. 33:750-754.
21. Stütz, A., and G. Petranyi. 1984. Synthesis and antifungal activity of (E)-N-(6,6-dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalenemethanamine (SF 86-327) and related allylamine derivatives with enhanced oral activity. J. Med. Chem. 27:1539-1543.
22. Takahashi, H. 1991. New topical imidazoles under development in Japan. TJN-318 (NND-318): evaluation of antifungal activities and the results of clinical open study on dermatomycoses, p. 103-112. In H. Yamaguchi et al. (ed.), Recent progress in antifungal chemotherapy. Mercel Dekker Inc., New York, N.Y.
23. Uchida, K., M. Kudoh, and H. Yamaguchi. 1994. A study on effectiveness of treatment and prevention of relapse using topical administration of terbinafine in a guinea pig model for tinea pedis. Jpn. J. Antibiot. 47:1407-1412.
24. Wagner, W., and R. Reckers-Czaschka. 1987. Oxiconazole in dermatomycosis - a double-blind, randomized therapy compared with bifonazole. Mykosen 30:484-492.